Tapewire

NYSE · USD

BHC

Bausch Health Companies Inc.

Export transactions ↓
Tapewire entity
4363
SEC CIK
0000885590
Parsed reports
591

Last 12 months

Inside the activity.

1 purchase rows · 5 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 202510
Dec 202500
Jan 202600
Feb 202601
Mar 202602
Apr 202600
May 202601
Jun 202600
Jul 202600
Aug 202601
Sep 202600
Oct 202600

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
December 01, 2023 Filed Dec 5, 2023 21:35 UTC
Carson SeanaEVP, General Counsel
Tax withholdingCommon Shares, No Par Value 1,691 $7.36 $12,445.76
Disclosure

SEC source: 0001127602-23-028885 · form4.xml · nonDerivative · entry 1

Carson Seana · CIK 0001923756 · EVP, General Counsel

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 383,145

F1 · shares: This number represents common shares, no par value, of the Issuer withheld to satisfy the tax withholding obligations due upon vesting of Restricted Share Units.

Read SEC document
November 06, 2023 Filed Nov 6, 2023 22:06 UTC
Carson SeanaEVP, General Counsel
SaleCommon Shares, No Par Value 43 $7.61 $327.23
Disclosure

SEC source: 0001127602-23-026852 · form4.xml · nonDerivative · entry 2

Carson Seana · CIK 0001923756 · EVP, General Counsel

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 384,836

F2 · shares: Represents shares of common stock sold in the open market pursuant to a Rule 10b5-1 plan adopted by the Reporting Person on December 15, 2022.

Read SEC document
November 03, 2023 Filed Nov 6, 2023 22:06 UTC
Carson SeanaEVP, General Counsel
Tax withholdingCommon Shares, No Par Value 334 $7.57 $2,528.38
Disclosure

SEC source: 0001127602-23-026852 · form4.xml · nonDerivative · entry 1

Carson Seana · CIK 0001923756 · EVP, General Counsel

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 384,879

F1 · shares: This number represents common shares, no par value, of the Issuer withheld to satisfy the tax withholding obligations due upon vesting of Restricted Share Units.

Read SEC document
September 29, 2023 Filed Oct 2, 2023 20:29 UTC GrantCommon Shares, No Par Value 836 $8.22 $6,871.92
Disclosure

SEC source: 0001127602-23-025007 · form4.xml · nonDerivative · entry 1

WECHSLER AMY B · CIK 0001677300 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 168,402

F1 · shares: Reflects Restricted Share Units, each representing a contingent right to receive one common share, no par value, of Bausch Health Companies Inc.

Read SEC document
September 29, 2023 Filed Oct 2, 2023 20:28 UTC GrantCommon Shares, No Par Value 3,801 $8.22 $31,244.22
Disclosure

SEC source: 0001127602-23-025005 · form4.xml · nonDerivative · entry 1

ROBERTSON RUSSEL C · CIK 0001677301 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 218,438

F1 · shares: Reflects Restricted Share Units, each representing a contingent right to receive one common share, no par value, of Bausch Health Companies Inc.

Read SEC document
September 29, 2023 Filed Oct 2, 2023 20:27 UTC
Paulson JohnDirector
GrantCommon Shares, No Par Value 7,603 $8.22 $62,496.66
Disclosure

SEC source: 0001127602-23-025004 · form4.xml · nonDerivative · entry 1

Paulson John · CIK 0001394923 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 194,626

F1 · shares: Reflects Restricted Share Units, each representing a contingent right to receive one common share, no par value, of Bausch Health Companies Inc.

Read SEC document
September 29, 2023 Filed Oct 2, 2023 20:25 UTC
ICAHN BRETTDirector
GrantCommon Shares, No Par Value 4,029 $8.22 $33,118.38
Disclosure

SEC source: 0001127602-23-025001 · form4.xml · nonDerivative · entry 1

ICAHN BRETT · CIK 0001387184 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 101,248

F1 · shares: Reflects Restricted Share Units, each representing a contingent right to receive one common share, no par value, of Bausch Health Companies Inc.

Read SEC document
September 06, 2023 Filed Sep 6, 2023 20:33 UTC
Carson SeanaEVP, General Counsel
SaleCommon Shares, No Par Value 6,685 $8.28 $55,351.80
Disclosure

SEC source: 0001127602-23-023786 · form4.xml · nonDerivative · entry 2

Carson Seana · CIK 0001923756 · EVP, General Counsel

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 385,213

F2 · shares: Represents shares of common stock sold in the open market pursuant to a Rule 10b5-1 plan adopted by the Reporting Person on December 15, 2022.

Read SEC document
September 05, 2023 Filed Sep 6, 2023 20:33 UTC
Carson SeanaEVP, General Counsel
Tax withholdingCommon Shares, No Par Value 51,337 $8.35 $428,663.95
Disclosure

SEC source: 0001127602-23-023786 · form4.xml · nonDerivative · entry 1

Carson Seana · CIK 0001923756 · EVP, General Counsel

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 391,898

F1 · shares: This number represents common shares, no par value, of the Issuer withheld to satisfy the tax withholding obligations due upon vesting of Restricted Share Units.

Read SEC document
September 05, 2023 Filed Sep 6, 2023 20:31 UTC
Barresi John SSVP, Controller & CAO
Tax withholdingCommon Shares, No Par Value 3,982 $8.35 $33,249.70
Disclosure

SEC source: 0001127602-23-023784 · form4.xml · nonDerivative · entry 1

Barresi John S · CIK 0001578223 · SVP, Controller & CAO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 71,126

F1 · shares: This number represents common shares, no par value, of the Issuer withheld to satisfy the tax withholding obligations due upon vesting of Restricted Share Units.

Read SEC document
September 05, 2023 Filed Sep 6, 2023 20:29 UTC
Vadaketh Tom GeorgeEVP, Chief Financial Officer
Tax withholdingCommon Shares, No Par Value 43,948 $8.35 $366,965.80
Disclosure

SEC source: 0001127602-23-023783 · form4.xml · nonDerivative · entry 1

Vadaketh Tom George · CIK 0001694891 · EVP, Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 564,933

F1 · shares: This number represents common shares, no par value, of the Issuer withheld to satisfy the tax withholding obligations due upon vesting of Restricted Share Units.

Read SEC document
September 01, 2023 Filed Sep 5, 2023 21:09 UTC
APPIO THOMASDirector · Chief Executive Officer
Tax withholdingCommon Shares, No Par Value 14,111 $8.46 $119,379.06
Disclosure

SEC source: 0001127602-23-023714 · form4.xml · nonDerivative · entry 1

APPIO THOMAS · CIK 0001683323 · Director · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 967,010

F1 · shares: This number represents common shares, no par value, of the Issuer withheld to satisfy the tax withholding obligations due upon vesting of Restricted Share Units.

Read SEC document
June 30, 2023 Filed Jul 5, 2023 20:09 UTC GrantCommon Shares, No Par Value 859 $8.00 $6,872.00
Disclosure

SEC source: 0001127602-23-020005 · form4.xml · nonDerivative · entry 1

WECHSLER AMY B · CIK 0001677300 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 167,566

F1 · shares: Reflects Restricted Share Units, each representing a contingent right to receive one common share, no par value, of Bausch Health Companies Inc.

Read SEC document
June 30, 2023 Filed Jul 5, 2023 20:07 UTC
ICAHN BRETTDirector
GrantCommon Shares, No Par Value 4,140 $8.00 $33,120.00
Disclosure

SEC source: 0001127602-23-020001 · form4.xml · nonDerivative · entry 1

ICAHN BRETT · CIK 0001387184 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 97,219

F1 · shares: Reflects Restricted Share Units, each representing a contingent right to receive one common share, no par value, of Bausch Health Companies Inc.

Read SEC document
June 30, 2023 Filed Jul 5, 2023 20:06 UTC
Paulson JohnDirector
GrantCommon Shares, No Par Value 7,812 $8.00 $62,496.00
Disclosure

SEC source: 0001127602-23-019997 · form4.xml · nonDerivative · entry 1

Paulson John · CIK 0001394923 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 187,023

F1 · shares: Reflects Restricted Share Units, each representing a contingent right to receive one common share, no par value, of Bausch Health Companies Inc.

Read SEC document
June 30, 2023 Filed Jul 5, 2023 20:01 UTC GrantCommon Shares, No Par Value 3,906 $8.00 $31,248.00
Disclosure

SEC source: 0001127602-23-019985 · form4.xml · nonDerivative · entry 1

ROBERTSON RUSSEL C · CIK 0001677301 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 214,637

F1 · shares: Reflects Restricted Share Units, each representing a contingent right to receive one common share, no par value, of Bausch Health Companies Inc.

Read SEC document
June 20, 2023 Filed Jun 21, 2023 20:10 UTC
Barresi John SSVP, Controller & CAO
Tax withholdingCommon Shares, No Par Value 1,929 $7.40 $14,274.60
Disclosure

SEC source: 0001127602-23-019149 · form4.xml · nonDerivative · entry 1

Barresi John S · CIK 0001578223 · SVP, Controller & CAO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 75,108

F1 · shares: This number represents common shares, no par value, of the Issuer withheld to satisfy the tax withholding obligations due upon vesting of Restricted Share Units.

Read SEC document
May 19, 2023 Filed May 19, 2023 20:27 UTC
Paulson JohnDirector
GrantCommon Shares, No Par Value 29,205 $0.00 $0.00
Disclosure

SEC source: 0001127602-23-016304 · form4.xml · nonDerivative · entry 1

Paulson John · CIK 0001394923 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 179,211

F1 · shares: Represents the award of restricted share units ("RSUs") granted to non-employee directors of the Issuer on the third business day following their election at the Issuer's Annual Meeting of Shareholders. The RSUs have a grant date value equal to $250,000, vest immediately prior to the Issuer's next Annual Meeting of Shareholders, and are settled in common shares, no par value, of the Issuer.

Read SEC document
May 19, 2023 Filed May 19, 2023 20:26 UTC GrantCommon Shares, No Par Value 29,205 $0.00 $0.00
Disclosure

SEC source: 0001127602-23-016302 · form4.xml · nonDerivative · entry 1

WECHSLER AMY B · CIK 0001677300 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 166,707

F1 · shares: Represents the award of restricted share units ("RSUs") granted to non-employee directors of the Issuer on the third business day following their election at the Issuer's Annual Meeting of Shareholders. The RSUs have a grant date value equal to $250,000, vest immediately prior to the Issuer's next Annual Meeting of Shareholders, and are settled in common shares, no par value, of the Issuer.

Read SEC document
May 19, 2023 Filed May 19, 2023 20:24 UTC GrantCommon Shares, No Par Value 29,205 $0.00 $0.00
Disclosure

SEC source: 0001127602-23-016300 · form4.xml · nonDerivative · entry 1

Ross Thomas W. Sr. · CIK 0001669396 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 161,516

F1 · shares: Represents the award of restricted share units ("RSUs") granted to non-employee directors of the Issuer on the third business day following their election at the Issuer's Annual Meeting of Shareholders. The RSUs have a grant date value equal to $250,000, vest immediately prior to the Issuer's next Annual Meeting of Shareholders, and are settled in common shares, no par value, of the Issuer.

Read SEC document
May 19, 2023 Filed May 19, 2023 20:20 UTC GrantCommon Shares, No Par Value 29,205 $0.00 $0.00
Disclosure

SEC source: 0001127602-23-016296 · form4.xml · nonDerivative · entry 1

ROBERTSON RUSSEL C · CIK 0001677301 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 210,731

F1 · shares: Represents the award of restricted share units ("RSUs") granted to non-employee directors of the Issuer on the third business day following their election at the Issuer's Annual Meeting of Shareholders. The RSUs have a grant date value equal to $250,000, vest immediately prior to the Issuer's next Annual Meeting of Shareholders, and are settled in common shares, no par value, of the Issuer.

Read SEC document
May 19, 2023 Filed May 19, 2023 20:19 UTC GrantCommon Shares, No Par Value 29,205 $0.00 $0.00
Disclosure

SEC source: 0001127602-23-016293 · form4.xml · nonDerivative · entry 1

POWER ROBERT N · CIK 0001187303 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 165,016

F1 · shares: Represents the award of restricted share units ("RSUs") granted to non-employee directors of the Issuer on the third business day following their election at the Issuer's Annual Meeting of Shareholders. The RSUs have a grant date value equal to $250,000, vest immediately prior to the Issuer's next Annual Meeting of Shareholders, and are settled in common shares, no par value, of the Issuer.

Read SEC document
May 19, 2023 Filed May 19, 2023 20:14 UTC GrantCommon Shares, No Par Value 29,205 $0.00 $0.00
Disclosure

SEC source: 0001127602-23-016288 · form4.xml · nonDerivative · entry 1

Miller Steven D · CIK 0001844277 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 139,517

F1 · shares: Represents the award of restricted share units ("RSUs") granted to non-employee directors of the Issuer on the third business day following their election at the Issuer's Annual Meeting of Shareholders. The RSUs have a grant date value equal to $250,000, vest immediately prior to the Issuer's next Annual Meeting of Shareholders, and are settled in common shares, no par value, of the Issuer.

Read SEC document
May 19, 2023 Filed May 19, 2023 20:16 UTC GrantCommon Shares, No Par Value 29,205 $0.00 $0.00
Disclosure

SEC source: 0001127602-23-016290 · form4.xml · nonDerivative · entry 1

Mulligan Richard · CIK 0001376247 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 65,909

F1 · shares: Represents the award of restricted share units ("RSUs") granted to non-employee directors of the Issuer on the third business day following their election at the Issuer's Annual Meeting of Shareholders. The RSUs have a grant date value equal to $250,000, vest immediately prior to the Issuer's next Annual Meeting of Shareholders, and are settled in common shares, no par value, of the Issuer.

Read SEC document
May 19, 2023 Filed May 19, 2023 20:13 UTC GrantCommon Shares, No Par Value 29,205 $0.00 $0.00
Disclosure

SEC source: 0001127602-23-016285 · form4.xml · nonDerivative · entry 1

KAVANAGH SARAH B · CIK 0001681171 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 146,652

F1 · shares: Represents the award of restricted share units ("RSUs") granted to non-employee directors of the Issuer on the third business day following their election at the Issuer's Annual Meeting of Shareholders. The RSUs have a grant date value equal to $250,000, vest immediately prior to the Issuer's next Annual Meeting of Shareholders, and are settled in common shares, no par value, of the Issuer.

Read SEC document
May 19, 2023 Filed May 19, 2023 20:11 UTC
ICAHN BRETTDirector
GrantCommon Shares, No Par Value 29,205 $0.00 $0.00
Disclosure

SEC source: 0001127602-23-016281 · form4.xml · nonDerivative · entry 1

ICAHN BRETT · CIK 0001387184 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 93,079

F1 · shares: Represents the award of restricted share units ("RSUs") granted to non-employee directors of the Issuer on the third business day following their election at the Issuer's Annual Meeting of Shareholders. The RSUs have a grant date value equal to $250,000, vest immediately prior to the Issuer's next Annual Meeting of Shareholders, and are settled in common shares, no par value, of the Issuer.

Read SEC document
March 31, 2023 Filed Apr 4, 2023 22:07 UTC GrantCommon Shares, No Par Value 848 $8.10 $6,868.80
Disclosure

SEC source: 0001127602-23-012413 · form4.xml · nonDerivative · entry 1

WECHSLER AMY B · CIK 0001677300 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 137,502

F1 · shares: Reflects Restricted Share Units, each representing a contingent right to receive one common share, no par value, of Bausch Health Companies Inc.

Read SEC document
March 31, 2023 Filed Apr 4, 2023 22:06 UTC GrantCommon Shares, No Par Value 4,110 $8.10 $33,291.00
Disclosure

SEC source: 0001127602-23-012412 · form4.xml · nonDerivative · entry 1

ROBERTSON RUSSEL C · CIK 0001677301 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 181,526

F1 · shares: Reflects Restricted Share Units, each representing a contingent right to receive one common share, no par value, of Bausch Health Companies Inc.

Read SEC document
March 31, 2023 Filed Apr 4, 2023 22:04 UTC
Paulson JohnDirector
GrantCommon Shares, No Par Value 7,716 $8.10 $62,499.60
Disclosure

SEC source: 0001127602-23-012411 · form4.xml · nonDerivative · entry 1

Paulson John · CIK 0001394923 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 150,006

F1 · shares: Reflects Restricted Share Units, each representing a contingent right to receive one common share, no par value, of Bausch Health Companies Inc.

Read SEC document
March 31, 2023 Filed Apr 4, 2023 22:03 UTC
ICAHN BRETTDirector
GrantCommon Shares, No Par Value 3,684 $8.10 $29,840.40
Disclosure

SEC source: 0001127602-23-012410 · form4.xml · nonDerivative · entry 1

ICAHN BRETT · CIK 0001387184 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 63,874

F1 · shares: Reflects Restricted Share Units, each representing a contingent right to receive one common share, no par value, of Bausch Health Companies Inc.

Read SEC document
March 31, 2023 Filed Apr 4, 2023 22:02 UTC GrantCommon Shares, No Par Value 3,642 $8.10 $29,500.20
Disclosure

SEC source: 0001127602-23-012409 · form4.xml · nonDerivative · entry 1

DE SCHUTTER RICHARD U · CIK 0001083205 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 373,407

F1 · shares: Reflects Restricted Share Units, each representing a contingent right to receive one common share, no par value, of Bausch Health Companies Inc.

Read SEC document
March 06, 2023 Filed Mar 6, 2023 21:52 UTC
Carson SeanaEVP, General Counsel
Tax withholdingCommon Shares, No Par Value 495 $9.17 $4,539.15
Disclosure

SEC source: 0001127602-23-009099 · form4.xml · nonDerivative · entry 8

Carson Seana · CIK 0001923756 · EVP, General Counsel

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 443,235

F4 · shares: Represents shares of common stock sold in the open market pursuant to a Rule 10b5-1 plan adopted by the Reporting Person on December 15, 2022.

Read SEC document
March 06, 2023 Filed Mar 7, 2023 21:50 UTC Amendment
Carson SeanaEVP, General Counsel
SaleCommon Shares, No Par Value 495 $9.17 $4,539.15
Disclosure

SEC source: 0001127602-23-009310 · form4a.xml · nonDerivative · entry 2

Carson Seana · CIK 0001923756 · EVP, General Counsel

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 443,235

F1 · shares: Represents shares of common stock sold in the open market pursuant to a Rule 10b5-1 plan adopted by the Reporting Person on December 15, 2022.

F2 · shares: This Form 4/A is being filed to correct the transaction code originally used to report this transaction on a Form 4 filed by the Reporting Person on 03/06/23. Due to an inadvertent administrative error, this transaction was originally incorrectly reported using code "F" instead of transaction code "S".

Read SEC document
March 03, 2023 Filed Mar 6, 2023 21:52 UTC
Carson SeanaEVP, General Counsel
Tax withholdingCommon Shares, No Par Value 780 $9.34 $7,285.20
Disclosure

SEC source: 0001127602-23-009099 · form4.xml · nonDerivative · entry 7

Carson Seana · CIK 0001923756 · EVP, General Counsel

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 443,730

F4 · shares: Represents shares of common stock sold in the open market pursuant to a Rule 10b5-1 plan adopted by the Reporting Person on December 15, 2022.

Read SEC document
March 03, 2023 Filed Mar 6, 2023 21:52 UTC
Carson SeanaEVP, General Counsel
Tax withholdingCommon Shares, No Par Value 887 $9.16 $8,124.92
Disclosure

SEC source: 0001127602-23-009099 · form4.xml · nonDerivative · entry 6

Carson Seana · CIK 0001923756 · EVP, General Counsel

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 444,510

F3 · shares: This number represents common shares, no par value, of the Issuer withheld to satisfy the tax withholding obligations due upon vesting of performance-based Restricted Share Units.

Read SEC document
March 03, 2023 Filed Mar 6, 2023 21:52 UTC
Carson SeanaEVP, General Counsel
Tax withholdingCommon Shares, No Par Value 1,637 $9.16 $14,994.92
Disclosure

SEC source: 0001127602-23-009099 · form4.xml · nonDerivative · entry 5

Carson Seana · CIK 0001923756 · EVP, General Counsel

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 445,397

F3 · shares: This number represents common shares, no par value, of the Issuer withheld to satisfy the tax withholding obligations due upon vesting of performance-based Restricted Share Units.

Read SEC document
March 03, 2023 Filed Mar 6, 2023 21:52 UTC
Carson SeanaEVP, General Counsel
Tax withholdingCommon Shares, No Par Value 511 $9.16 $4,680.76
Disclosure

SEC source: 0001127602-23-009099 · form4.xml · nonDerivative · entry 4

Carson Seana · CIK 0001923756 · EVP, General Counsel

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 447,034

F1 · shares: This number represents common shares, no par value, of the Issuer withheld to satisfy the tax withholding obligations due upon vesting of Restricted Share Units.

Read SEC document
March 03, 2023 Filed Mar 6, 2023 21:52 UTC
Carson SeanaEVP, General Counsel
Tax withholdingCommon Shares, No Par Value 765 $9.16 $7,007.40
Disclosure

SEC source: 0001127602-23-009099 · form4.xml · nonDerivative · entry 3

Carson Seana · CIK 0001923756 · EVP, General Counsel

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 447,545

F1 · shares: This number represents common shares, no par value, of the Issuer withheld to satisfy the tax withholding obligations due upon vesting of Restricted Share Units.

Read SEC document
March 03, 2023 Filed Mar 6, 2023 21:49 UTC
APPIO THOMASDirector · Chief Executive Officer
Tax withholdingCommon Shares, No Par Value 2,357 $9.16 $21,590.12
Disclosure

SEC source: 0001127602-23-009096 · form4.xml · nonDerivative · entry 6

APPIO THOMAS · CIK 0001683323 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 981,121

F3 · shares: This number represents common shares, no par value, of the Issuer withheld to satisfy the tax withholding obligations due upon vesting of performance-based Restricted Share Units.

Read SEC document
March 03, 2023 Filed Mar 6, 2023 21:49 UTC
APPIO THOMASDirector · Chief Executive Officer
Tax withholdingCommon Shares, No Par Value 4,348 $9.16 $39,827.68
Disclosure

SEC source: 0001127602-23-009096 · form4.xml · nonDerivative · entry 5

APPIO THOMAS · CIK 0001683323 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 983,478

F3 · shares: This number represents common shares, no par value, of the Issuer withheld to satisfy the tax withholding obligations due upon vesting of performance-based Restricted Share Units.

Read SEC document
March 03, 2023 Filed Mar 6, 2023 21:49 UTC
APPIO THOMASDirector · Chief Executive Officer
Tax withholdingCommon Shares, No Par Value 1,577 $9.16 $14,445.32
Disclosure

SEC source: 0001127602-23-009096 · form4.xml · nonDerivative · entry 4

APPIO THOMAS · CIK 0001683323 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 987,826

F1 · shares: This number represents common shares, no par value, of the Issuer withheld to satisfy the tax withholding obligations due upon vesting of Restricted Share Units.

Read SEC document
March 03, 2023 Filed Mar 6, 2023 21:49 UTC
APPIO THOMASDirector · Chief Executive Officer
Tax withholdingCommon Shares, No Par Value 1,893 $9.16 $17,339.88
Disclosure

SEC source: 0001127602-23-009096 · form4.xml · nonDerivative · entry 3

APPIO THOMAS · CIK 0001683323 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 989,403

F1 · shares: This number represents common shares, no par value, of the Issuer withheld to satisfy the tax withholding obligations due upon vesting of Restricted Share Units.

Read SEC document
March 03, 2023 Filed Mar 7, 2023 21:50 UTC Amendment
Carson SeanaEVP, General Counsel
SaleCommon Shares, No Par Value 780 $9.34 $7,285.20
Disclosure

SEC source: 0001127602-23-009310 · form4a.xml · nonDerivative · entry 1

Carson Seana · CIK 0001923756 · EVP, General Counsel

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 443,730

F1 · shares: Represents shares of common stock sold in the open market pursuant to a Rule 10b5-1 plan adopted by the Reporting Person on December 15, 2022.

F2 · shares: This Form 4/A is being filed to correct the transaction code originally used to report this transaction on a Form 4 filed by the Reporting Person on 03/06/23. Due to an inadvertent administrative error, this transaction was originally incorrectly reported using code "F" instead of transaction code "S".

Read SEC document
March 02, 2023 Filed Mar 6, 2023 21:52 UTC
Carson SeanaEVP, General Counsel
GrantNon-Qualified Stock Options (right to purchase) · Derivative 82,117 $0.00 Strike: $9.25 $0.00
Disclosure

SEC source: 0001127602-23-009099 · form4.xml · derivative · entry 9

Carson Seana · CIK 0001923756 · EVP, General Counsel

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 82,117

Underlying: Common Shares, No Par Value · 82,117 shares

Expires 2033-03-02

F5 · derivative.exercise_date: The options vest in equal installments on each of the first three anniversaries of the date of grant.

Read SEC document
March 02, 2023 Filed Mar 6, 2023 21:52 UTC
Carson SeanaEVP, General Counsel
GrantCommon Shares, No Par Value 95,119 $0.00 $0.00
Disclosure

SEC source: 0001127602-23-009099 · form4.xml · nonDerivative · entry 2

Carson Seana · CIK 0001923756 · EVP, General Counsel

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 448,310

F2 · shares: Represents the award of restricted share units ("RSUs") which will vest one-third on each of the first three anniversaries following the date of grant, subject to the reporting person's continued service. Vested RSUs are settled in common shares, no par value, of Bausch Health Companies Inc.

Read SEC document
March 02, 2023 Filed Mar 6, 2023 21:52 UTC
Carson SeanaEVP, General Counsel
Tax withholdingCommon Shares, No Par Value 5,994 $9.25 $55,444.50
Disclosure

SEC source: 0001127602-23-009099 · form4.xml · nonDerivative · entry 1

Carson Seana · CIK 0001923756 · EVP, General Counsel

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 353,191

F1 · shares: This number represents common shares, no par value, of the Issuer withheld to satisfy the tax withholding obligations due upon vesting of Restricted Share Units.

Read SEC document
March 02, 2023 Filed Mar 6, 2023 21:49 UTC
APPIO THOMASDirector · Chief Executive Officer
GrantCommon Shares, No Par Value 523,155 $0.00 $0.00
Disclosure

SEC source: 0001127602-23-009096 · form4.xml · nonDerivative · entry 2

APPIO THOMAS · CIK 0001683323 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 991,296

F2 · shares: Represents the award of restricted share units ("RSUs") which will vest one-third on each of the first three anniversaries following the date of grant, subject to the reporting person's continued service. Vested RSUs are settled in common shares, no par value, of Bausch Health Companies Inc.

Read SEC document
March 02, 2023 Filed Mar 6, 2023 21:49 UTC
APPIO THOMASDirector · Chief Executive Officer
Tax withholdingCommon Shares, No Par Value 17,432 $9.25 $161,246.00
Disclosure

SEC source: 0001127602-23-009096 · form4.xml · nonDerivative · entry 1

APPIO THOMAS · CIK 0001683323 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 468,141

F1 · shares: This number represents common shares, no par value, of the Issuer withheld to satisfy the tax withholding obligations due upon vesting of Restricted Share Units.

Read SEC document
March 02, 2023 Filed Mar 6, 2023 21:48 UTC
Vadaketh Tom GeorgeEVP, Chief Financial Officer
GrantNon-Qualified Stock Options (right to purchase) · Derivative 123,177 $0.00 Strike: $9.25 $0.00
Disclosure

SEC source: 0001127602-23-009095 · form4.xml · derivative · entry 3

Vadaketh Tom George · CIK 0001694891 · EVP, Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 123,177

Underlying: Common Shares, No Par Value · 123,177 shares

Expires 2033-03-02

F3 · derivative.exercise_date: The options vest in equal installments on each of the first three anniversaries of the date of grant.

Read SEC document
March 02, 2023 Filed Mar 6, 2023 21:48 UTC
Vadaketh Tom GeorgeEVP, Chief Financial Officer
GrantCommon Shares, No Par Value 142,678 $0.00 $0.00
Disclosure

SEC source: 0001127602-23-009095 · form4.xml · nonDerivative · entry 2

Vadaketh Tom George · CIK 0001694891 · EVP, Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 608,881

F2 · shares: Represents the award of restricted share units ("RSUs") which will vest one-third on each of the first three anniversaries following the date of grant, subject to the reporting person's continued service. Vested RSUs are settled in common shares, no par value, of Bausch Health Companies Inc.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.